Yang Yao

Summary

Publications

  1. ncbi request reprint [Short-term effects of chemotherapy combined with hydroxycamptothecine and oxaliplatin in treatment of recurrent and metastatic colorectal cancer]
    Yang Yao
    Department of Medical Oncology, The Sixth People s Hospital, Shanghai Jiaotong University, Shanghai, 200233, P R China
    Ai Zheng 25:1035-8. 2006
  2. ncbi request reprint Oxaliplatin plus hydroxycamptothecine versus oxaliplatin plus 5-fluorouracil and leucovorin in treatment of advanced colorectal cancer
    Yang Yao
    Department of Oncology, Shanghai Sixth People s Hospital of Shanghai JiaoTong University, Shanghai 200233, China
    Chin Med J (Engl) 119:1829-33. 2006
  3. doi request reprint Comparison between doublet agents versus single agent in metastatic breast cancer patients previously treated with an anthracycline and a taxane: a meta-analysis of four phase III trials
    Wei Xiang Qi
    Department of Oncology, The Sixth People s Hospital, Shanghai Jiao Tong University, No 600 Yishan Road, Shanghai, China
    Breast 22:314-9. 2013
  4. pmc Incidence and risk of hypertension with vandetanib in cancer patients: a systematic review and meta-analysis of clinical trials
    Wei Xiang Qi
    Department of Oncology, The Sixth People s Hospital, Shanghai Jiao Tong University, No 600, Yishan Road, Shanghai, 200233, China
    Br J Clin Pharmacol 75:919-30. 2013
  5. ncbi request reprint [Short-term effects of chemotherapy with combination of hydroxycamptothecine and oxaliplatin in the treatment of advanced digestive tract cancers]
    Yuan jue Sun
    Department of Medical Oncology, Sixth People s Hospital, Shanghai University of Commanications, Shanghai 200233, China
    Zhonghua Zhong Liu Za Zhi 26:749-52. 2004
  6. ncbi request reprint Analysis of prognostic factors in 333 Chinese patients with high-grade osteosarcoma treated by multidisciplinary combined therapy
    Daliu Min
    Department of Medical Oncology, The Affiliated 6th People s Hospital of Shanghai Jiaotong University, Shanghai, China
    Asia Pac J Clin Oncol 9:71-9. 2013
  7. ncbi request reprint Mediator of RNA polymerase II transcription subunit 19 promotes osteosarcoma growth and metastasis and associates with prognosis
    Wenxi Yu
    Department of Oncology, Affiliated Sixth People s Hospital, Shanghai Jiaotong University, 200233 Shanghai, People s Republic of China
    Eur J Cancer 50:1125-36. 2014
  8. doi request reprint Comparison of pirarubicin-based versus gemcitabine-docetaxel chemotherapy for relapsed and refractory osteosarcoma: a single institution experience
    Aina He
    Department of Oncology, The Sixth People s Hospital, Shanghai Jiao Tong University, Shanghai, 200233, China
    Int J Clin Oncol 18:498-505. 2013
  9. doi request reprint Risk of venous thromboembolic events associated with VEGFR-TKIs: a systematic review and meta-analysis
    Wei Xiang Qi
    Department of Oncology, The Sixth People s Hospital, Shanghai Jiao Tong University, Shanghai 200233, China
    Int J Cancer 132:2967-74. 2013
  10. doi request reprint Incidence and risk of treatment-related mortality in cancer patients treated with EGFR-TKIs: a meta-analysis of 22 phase III randomized controlled trials
    Wei Xiang Qi
    Department of Oncology, The Sixth People s Hospital, Shanghai Jiao Tong University, No 600, Yishan Road, Shanghai 200233, China
    Respir Med 107:1280-3. 2013

Collaborators

Detail Information

Publications49

  1. ncbi request reprint [Short-term effects of chemotherapy combined with hydroxycamptothecine and oxaliplatin in treatment of recurrent and metastatic colorectal cancer]
    Yang Yao
    Department of Medical Oncology, The Sixth People s Hospital, Shanghai Jiaotong University, Shanghai, 200233, P R China
    Ai Zheng 25:1035-8. 2006
    ..This study was to evaluate the short-term effects and toxicity of combination of hydroxycamptothecine (HCPT) plus oxaliplatin (L-OHP) protocol in the treatment of recurrent and metastatic colorectal cancer...
  2. ncbi request reprint Oxaliplatin plus hydroxycamptothecine versus oxaliplatin plus 5-fluorouracil and leucovorin in treatment of advanced colorectal cancer
    Yang Yao
    Department of Oncology, Shanghai Sixth People s Hospital of Shanghai JiaoTong University, Shanghai 200233, China
    Chin Med J (Engl) 119:1829-33. 2006
  3. doi request reprint Comparison between doublet agents versus single agent in metastatic breast cancer patients previously treated with an anthracycline and a taxane: a meta-analysis of four phase III trials
    Wei Xiang Qi
    Department of Oncology, The Sixth People s Hospital, Shanghai Jiao Tong University, No 600 Yishan Road, Shanghai, China
    Breast 22:314-9. 2013
    ..To compare doublet agents with single agent as salvage treatment in metastatic breast cancer (MBC) patients pre-treated with an anthracycline and a taxane...
  4. pmc Incidence and risk of hypertension with vandetanib in cancer patients: a systematic review and meta-analysis of clinical trials
    Wei Xiang Qi
    Department of Oncology, The Sixth People s Hospital, Shanghai Jiao Tong University, No 600, Yishan Road, Shanghai, 200233, China
    Br J Clin Pharmacol 75:919-30. 2013
    ..To perform a systematic review and meta-analysis of published clinical trials to determine incidence rate and overall risk of hypertension with vandetanib in cancer patients...
  5. ncbi request reprint [Short-term effects of chemotherapy with combination of hydroxycamptothecine and oxaliplatin in the treatment of advanced digestive tract cancers]
    Yuan jue Sun
    Department of Medical Oncology, Sixth People s Hospital, Shanghai University of Commanications, Shanghai 200233, China
    Zhonghua Zhong Liu Za Zhi 26:749-52. 2004
    ..To evaluate the short-term therapeutic effects and side effects of combined hydroxycamptothecine and oxaliplatin in the treatment of advanced digestive tract cancers...
  6. ncbi request reprint Analysis of prognostic factors in 333 Chinese patients with high-grade osteosarcoma treated by multidisciplinary combined therapy
    Daliu Min
    Department of Medical Oncology, The Affiliated 6th People s Hospital of Shanghai Jiaotong University, Shanghai, China
    Asia Pac J Clin Oncol 9:71-9. 2013
    ..To investigate prognostic factors for long-term outcomes in Chinese patients with high-grade osteosarcoma of the extremities or trunk treated by multidisciplinary combined therapy...
  7. ncbi request reprint Mediator of RNA polymerase II transcription subunit 19 promotes osteosarcoma growth and metastasis and associates with prognosis
    Wenxi Yu
    Department of Oncology, Affiliated Sixth People s Hospital, Shanghai Jiaotong University, 200233 Shanghai, People s Republic of China
    Eur J Cancer 50:1125-36. 2014
    ..Med19 depletion remarkably reduced tumour metastasis in a model of OS metastatic spreading. Taken together, our data suggest that Med19 acts as an oncogene in OS via a possible cyclin D1/cyclin B1 modulation pathway. ..
  8. doi request reprint Comparison of pirarubicin-based versus gemcitabine-docetaxel chemotherapy for relapsed and refractory osteosarcoma: a single institution experience
    Aina He
    Department of Oncology, The Sixth People s Hospital, Shanghai Jiao Tong University, Shanghai, 200233, China
    Int J Clin Oncol 18:498-505. 2013
    ..We conducted this retrospective study to compare the feasibility and efficacy of pirarubicin-based chemotherapy with gemcitabine-docetaxel combination regimens for the salvage of these patients...
  9. doi request reprint Risk of venous thromboembolic events associated with VEGFR-TKIs: a systematic review and meta-analysis
    Wei Xiang Qi
    Department of Oncology, The Sixth People s Hospital, Shanghai Jiao Tong University, Shanghai 200233, China
    Int J Cancer 132:2967-74. 2013
    ..These results would provide important information for clinicians who use VEGFR-TKIs to treat patients with solid cancer...
  10. doi request reprint Incidence and risk of treatment-related mortality in cancer patients treated with EGFR-TKIs: a meta-analysis of 22 phase III randomized controlled trials
    Wei Xiang Qi
    Department of Oncology, The Sixth People s Hospital, Shanghai Jiao Tong University, No 600, Yishan Road, Shanghai 200233, China
    Respir Med 107:1280-3. 2013
    ....
  11. pmc Overall survival benefits for combining targeted therapy as second-line treatment for advanced non-small-cell-lung cancer: a meta-analysis of published data
    Wei Xiang Qi
    Department of Oncology, The Sixth People s Hospital, Shanghai Jiao Tong University, Shanghai, China
    PLoS ONE 8:e55637. 2013
    ..We thus performed a meta-analysis of randomized controlled trials to compare the efficacy and safety of combining targeted therapy versus erlotinib alone as second-line treatment for advanced NSCLC...
  12. doi request reprint Overall survival benefits for irinotecan-containing regimens as first-line treatment for advanced gastric cancer: an updated meta-analysis of ten randomized controlled trials
    Wei Xiang Qi
    Department of Oncology, The Sixth People s Hospital, Shanghai Jiao Tong University, Shanghai, China
    Int J Cancer 132:E66-73. 2013
    ..A clear advantage of irinotecan-containing over nonirinotecan-containing regimen had not been established. These results should help to inform decisions about patient management and design of future trials...
  13. ncbi request reprint Comparison of the efficacy and safety of EFGR tyrosine kinase inhibitor monotherapy with standard second-line chemotherapy in previously treated advanced non-small-cell lung cancer: a systematic review and meta-analysis
    Wei Xiang Qi
    Department of Oncology, Sixth People s Hospital, Shanghai Jiao Tong University, Shanghai, China
    Asian Pac J Cancer Prev 13:5177-82. 2012
    ....
  14. doi request reprint Relationships between levels of CXCR4 and VEGF and blood-borne metastasis and survival in patients with osteosarcoma
    Feng Lin
    Department of Oncology, Affiliated 6th People s Hospital, Shanghai Jiao Tong University, Shanghai, People s Republic of China
    Med Oncol 28:649-53. 2011
    ..03) or VEGF (P = 0.04). These data indicate that CXCR4 and VEGF expression is highly correlated with metastatic progression in patients with osteosarcoma and had predictive value for the metastasis and survival of osteosarcoma patients...
  15. ncbi request reprint The expression of CRM1 is associated with prognosis in human osteosarcoma
    Yang Yao
    Department of Oncology, Affiliated 6th People s Hospital, Shanghai Jiaotong University, Shanghai 200223, P R China
    Oncol Rep 21:229-35. 2009
    ..27-5.39). Additional prospective studies are required to investigate the prognostic role of high expression of CRM1...
  16. pmc Incidence and risk of hypertension with a novel multi-targeted kinase inhibitor axitinib in cancer patients: a systematic review and meta-analysis
    Wei Xiang Qi
    Department of Oncology, The Sixth People s Hospital, Shanghai Jiao Tong University, Shanghai, 200233, China
    Br J Clin Pharmacol 76:348-57. 2013
    ....
  17. pmc Risk of venous and arterial thromboembolic events in cancer patients treated with gemcitabine: a systematic review and meta-analysis
    Wei Xiang Qi
    Department of Oncology, The Sixth People s Hospital, Shanghai Jiao Tong University, Shanghai, China
    Br J Clin Pharmacol 76:338-47. 2013
    ..As indications for its use in oncology are expanding, a comprehensive characterization of these complications becomes imperative...
  18. pmc Incidence and risk of treatment-related mortality with mTOR inhibitors everolimus and temsirolimus in cancer patients: a meta-analysis
    Wei Xiang Qi
    Department of Oncology, The Sixth People s Hospital, Shanghai Jiao Tong University, Shanghai, China
    PLoS ONE 8:e65166. 2013
    ....
  19. doi request reprint Paclitaxel-based versus docetaxel-based regimens in metastatic breast cancer: a systematic review and meta-analysis of randomized controlled trials
    Wei Xiang Qi
    Department of Oncology, The Sixth People s Hospital, Shanghai Jiao Tong University, Shanghai, China
    Curr Med Res Opin 29:117-25. 2013
    ..We therefore performed a meta-analysis of randomized controlled trials to compare the safety and efficacy of these two regimens in MBC...
  20. doi request reprint Evaluation of pirarubicin-cisplatin chemotherapy in the treatment for refractory and recurrent high-grade osteosarcoma: experience of a single institute
    Wei Xiang Qi
    Department of Oncology, The Sixth People s Hospital, Shanghai Jiao Tong University, Shanghai 200233, China
    Med Oncol 29:2229-33. 2012
    ..THP-DDP regimen chemotherapy represents an active and well-tolerated treatment for Chinese refractory and recurrent high-grade osteosarcoma patients. Further assessment is necessary to confirm the safety and efficacy of this treatment...
  21. ncbi request reprint Doublet versus single cytotoxic agent as first-line treatment for elderly patients with advanced non-small-cell lung cancer: a systematic review and meta-analysis
    Wei Xiang Qi
    Department of Oncology, The Sixth People s Hospital, Shanghai Jiao Tong University, No 600, Yishan Road, Shanghai, 200233, China
    Lung 190:477-85. 2012
    ....
  22. doi request reprint Efficacy and safety of gemcitabine-docetaxel combination therapy for recurrent or refractory high-grade osteosarcoma in China: a retrospective study of 18 patients
    Wei Xiang Qi
    Department of Oncology, The Sixth People s Hospital, Shanghai Jiao Tong University, Shanghai 200233, China
    Jpn J Clin Oncol 42:427-31. 2012
    ..In this study, we describe experiences with gemcitabine-docetaxel combination therapy as salvage treatment for Chinese patients with recurrent or refractory high-grade osteosarcoma...
  23. doi request reprint Erlotinib and pemetrexed as maintenance therapy for advanced non-small-cell lung cancer: a systematic review and indirect comparison
    Wei Xiang Qi
    Department of Oncology, Sixth People s Hospital, Shanghai Jiao Tong University, Shanghai, China
    Curr Med Res Opin 28:643-50. 2012
    ..This paper aims to systematically review the evidence from all available clinical trials of erlotinib and pemetrexed as maintenance therapy for advanced NSCLC...
  24. doi request reprint Effectiveness and safety of pemetrexed-based doublet versus pemetrexed alone as second-line treatment for advanced non-small-cell lung cancer: a systematic review and meta-analysis
    Wei Xiang Qi
    Department of Oncology, The Sixth People Hospital, Shanghai Jiao Tong University, Shanghai, China
    J Cancer Res Clin Oncol 138:745-51. 2012
    ..To compared pemetrexed-based doublet with single-agent pemetrexed as second-line treatment for advanced non-small-cell lung cancer..
  25. ncbi request reprint Combined chemotherapy of hydroxycampothecin with oxaliplatin as an adjuvant treatment for human colorectal cancer
    Yang Yao
    Department of Medical Oncology, Sixth People s Hospital, Shanghai Jiaotong University, China
    Tohoku J Exp Med 215:267-78. 2008
    ..Taken together, the present study indicates that the combined chemotherapy of HCPT with L-OHP could become a new adjuvant treatment for CRC...
  26. doi request reprint Incidence and risk of denosumab-related hypocalcemia in cancer patients: a systematic review and pooled analysis of randomized controlled studies
    Wei Xiang Qi
    Department of Oncology, The Sixth People s Hospital, Shanghai Jiao Tong University, Shanghai, China
    Curr Med Res Opin 29:1067-73. 2013
    ..The aim of this study is to evaluate the frequency and relative risk of hypocalcemia in cancer patients receiving denosumab...
  27. doi request reprint The prognostic value of survivin expression in patients with colorectal carcinoma: a meta-analysis
    Yu Jing Huang
    Department of Oncology, The Sixth People s Hospital, Shanghai Jiao Tong University, No 600, Yishan Road, Shanghai 200233, China
    Jpn J Clin Oncol 43:988-95. 2013
    ..The prognostic role of survivin in colorectal carcinoma remains controversial. This meta-analysis aimed to explore the association between survivin expression and survival outcomes in patients with colorectal carcinoma...
  28. doi request reprint Incidence and risk of hypertension with pazopanib in patients with cancer: a meta-analysis
    Wei Xiang Qi
    Department of Oncology, The Sixth People s Hospital, Shanghai Jiao Tong University, No 600, Yishan Road, Shanghai 200233, China
    Cancer Chemother Pharmacol 71:431-9. 2013
    ..To gain a better understanding of the overall incidence and risk of hypertension in cancer patients who receive pazopanib and to compare the differences in incidence among sorafenib, sunitinib, and pazopanib...
  29. doi request reprint Meta-analysis of docetaxel-based doublet versus docetaxel alone as second-line treatment for advanced non-small-cell lung cancer
    Wei Xiang Qi
    Department of Oncology, The Sixth People Hospital, Medical College of Shanghai Jiao Tong University, Shanghai 200233, China
    Cancer Chemother Pharmacol 69:99-106. 2012
    ..To compare docetaxel-based doublet with single-agent docetaxel as second-line treatment in non-small-cell lung cancer (NSCLC)...
  30. pmc Prognostic value of Ezrin in solid tumors: a meta-analysis of the literature
    Kun Han
    Department of Oncology, Shanghai Sixth People s Hospital East Campus, Shanghai Jiao Tong University, Shanghai, China
    PLoS ONE 8:e68527. 2013
    ..Ezrin is a cytoskeletal protein involved in tumor growth and invasion. However its prognostic value for survival in patients with solid tumor remains controversial...
  31. ncbi request reprint Cyclophosphamide-hydroxycamptothecin as second-line chemotherapy for advanced Ewing's sarcoma: experience of a single institution
    Kun Han
    Department of Medical Oncology, The Sixth People s Hospital Affiliated to Shanghai Jiao Tong University, Shanghai, China
    Asia Pac J Clin Oncol 10:e114-7. 2014
    ..To investigate the feasibility and efficacy of cyclophosphamide (CTX)-hydroxycamptothecin (HCPT) as second-line chemotherapy on advanced Ewing's sarcoma...
  32. doi request reprint CT fluoroscopy-guided percutaneous osteoplasty for the treatment of osteolytic lung cancer bone metastases to the spine and pelvis
    Zhiyu Wang
    Department of Internal Oncology, Shanghai Jiaotong University, Shanghai, China
    J Vasc Interv Radiol 23:1135-42. 2012
    ..To retrospectively assess the results of computed tomographic (CT) fluoroscopy-guided percutaneous osteoplasty (PO) of osteolytic lung cancer bone metastases, focusing on pain reduction, improved quality of life, and patient mobility...
  33. doi request reprint Pirarubicin inhibits multidrug-resistant osteosarcoma cell proliferation through induction of G2/M phase cell cycle arrest
    Shui Er Zheng
    Department of Oncology, Affiliated People s 6th Hospital, Shanghai Jiao Tong University, China
    Acta Pharmacol Sin 33:832-8. 2012
    ..In this study, the effects of THP on the multidrug-resistant (MDR) osteosarcoma cells were assessed, and the underlying mechanisms for the disruption of cell cycle kinetics by THP were explored...
  34. doi request reprint Primary splenic angiosarcoma
    Zengjun Liu
    Shanghai No 6 Hospital, Shanghai, China
    Vasa 41:57-62. 2012
    ..The outcome of this disease is typically dismal with a mean survival of one to two years. However, our here presented case remained uncommonly symptom-free for nine years after splenectomy alone at the early phase of the disease...
  35. doi request reprint Clinical analysis of Chinese limb osteosarcoma patients treated by two combinations of methotrexate, cisplatin, doxorubicin and ifosfamide
    Feng Lin
    No 6 People s Hospital of Shanghai Jiaotong University, Shanghai, China
    Asia Pac J Clin Oncol 7:270-5. 2011
    ..The objective of this study was to investigate the efficacy and toxic side effects of two combinations of methotrexate, cisplatin, doxorubicin and ifosfamide on treating Chinese osteosarcoma patients...
  36. doi request reprint Percutaneous vertebroplasty combined with zoledronic acid for the treatment of painful osteolytic spinal metastases in patients with breast cancer
    Jianjun Zhang
    Department of Internal Oncology, Sixth People s Hospital, Shanghai Jiaotong University, 600 Yishan Road, Shanghai 200233, China
    J Vasc Interv Radiol 24:1861-7. 2013
    ..To assess retrospectively the efficacy and safety of percutaneous vertebroplasty (PVP) combined with zoledronic acid (ZA) for the treatment of painful osteolytic spinal metastases from breast cancer...
  37. ncbi request reprint Down-regulation of ribosomal protein L7A in human osteosarcoma
    Shui Er Zheng
    Department of Oncology, Affiliated People s 6th Hospital, Shanghai Jiaotong University, 200233 Shanghai, People s Republic of China
    J Cancer Res Clin Oncol 135:1025-31. 2009
    ..To explore the expression of ribosomal protein L7A (RPL7A) in osteosarcoma and its correlation with clinical features...
  38. doi request reprint Variances handling method of clinical pathways based on T-S fuzzy neural networks with novel hybrid learning algorithm
    Gang Du
    Department of Industrial Engineering and Logistics Management, Shanghai Jiao Tong University, Shanghai, China
    J Med Syst 36:1283-300. 2012
    ....
  39. doi request reprint The role of vandetanib in the second-line treatment for advanced non-small-cell-lung cancer: a meta-analysis of four randomized controlled trials
    Wei Xiang Qi
    Department of Oncology, The Sixth People s Hospital, Shanghai Jiao Tong University, Shanghai, 200233, China
    Lung 189:437-43. 2011
    ..The purpose of this study was to assess the efficacy and toxicity of vandetanib in the second-line treatment for advanced non-small cell lung cancer (NSCLC)...
  40. ncbi request reprint Risk of osteonecrosis of the jaw in cancer patients receiving denosumab: a meta-analysis of seven randomized controlled trials
    Wei Xiang Qi
    Department of Oncology, The Sixth People s Hospital, Shanghai Jiao Tong University, No 600, Yishan Road, Shanghai, 200233, China
    Int J Clin Oncol 19:403-10. 2014
    ..The aim of this study is to gain a better understanding of the overall incidence and risk of osteonecrosis of the jaw (ONJ) in cancer patients receiving denosumab...
  41. doi request reprint Risk of gastrointestinal perforation in cancer patients treated with vascular endothelial growth factor receptor tyrosine kinase inhibitors: a systematic review and meta-analysis
    Wei Xiang Qi
    Department of Oncology, The Sixth People s Hospital, Shanghai Jiao Tong University, No 600, Yishan Road, Shanghai 200233, China
    Crit Rev Oncol Hematol 89:394-403. 2014
    ..We conduct a systematic review and meta-analysis of published trials to evaluate the overall incidence and risk of GI perforation associated with VEGFR-TKIs...
  42. ncbi request reprint Prognostic value of tissue vascular endothelial growth factor expression in bladder cancer: a meta-analysis
    Yu Jing Huang
    Department of Oncology, Affiliated Sixth People s Hospital, Shanghai Jiaotong University, Shanghai, China
    Asian Pac J Cancer Prev 14:645-9. 2013
    ..The prognostic role of vascular endothelial growth factor (VEGF) in bladder cancer remains controversial. This meta-analysis aimed to explore any association between overexpression and survival outcomes...
  43. pmc Value of C-telopeptide-cross-linked Type I collagen, osteocalcin, bone-specific alkaline phosphatase and procollagen Type I N-terminal propeptide in the diagnosis and prognosis of bone metastasis in patients with malignant tumors
    Hui Zhao
    Department of Internal Oncology, Sixth People s Hospital, Shanghai Jiaotong University, Shanghai, China
    Med Sci Monit 17:CR626-633. 2011
    ..The present study aimed to investigate the value of biochemical markers of bone turnover in the diagnosis and prognosis of bone metastases of malignant tumors...
  44. doi request reprint Treatment-related mortality with aflibercept in cancer patients: a meta-analysis
    Wei Xiang Qi
    Department of Oncology, Shanghai Jiao Tong University Affiliated Sixth People s Hospital, No 600, Yishan Road, Shanghai, 200233, China
    Eur J Clin Pharmacol 70:461-7. 2014
    ..We carried out an up-to-date meta-analysis to determine the risk of fatal adverse events (FAEs) in cancer patients treated with aflibercept...
  45. doi request reprint Risk of hypertension in cancer patients treated with aflibercept: a systematic review and meta-analysis
    Wei Xiang Qi
    Department of Oncology, Shanghai Jiao Tong University Affiliated Sixth People s Hospital, No 600, Yishan Road, Shanghai, 200233, China
    Clin Drug Investig 34:231-40. 2014
    ..Hypertension is one of its major adverse effects with a substantial variation in the reported incidences and has not been systematically investigated...
  46. ncbi request reprint Bevacizumab increases the risk of gastrointestinal perforation in cancer patients: a meta-analysis with a focus on different subgroups
    Wei Xiang Qi
    Department of Oncology, Shanghai Jiao Tong University Affiliated Sixth People s Hospital, No 600, Yishan Road, Shanghai, 200233, China
    Eur J Clin Pharmacol 70:893-906. 2014
    ..The aim of this meta-analysis was to gather current data and evaluate not only the risk of gastrointestinal (GI) perforation with bevacizumab, but also the potential risk factors for this adverse event...
  47. ncbi request reprint Clinical pathways scheduling using hybrid genetic algorithm
    Gang Du
    Business School, East China Normal University, 500 Dong Chuan Road, Shanghai, 200241, China
    J Med Syst 37:9945. 2013
    ..This research has both theoretical and practical significance for electronic CP management, in particular...
  48. doi request reprint Docetaxel-based therapy with or without estramustine as first-line chemotherapy for castration-resistant prostate cancer: a meta-analysis of four randomized controlled trials
    Wei Xiang Qi
    Department of Oncology, The Sixth People Hospital, Shanghai Jiao Tong University, Shanghai, 200233, China
    J Cancer Res Clin Oncol 137:1785-90. 2011
    ..To assess the efficacy and toxicity of the addition of estramustine to docetaxel-based chemotherapy for the treatment of castration-resistant prostate cancer...
  49. doi request reprint Knowledge extraction algorithm for variances handling of CP using integrated hybrid genetic double multi-group cooperative PSO and DPSO
    Gang Du
    Department of Industrial Engineering and Logistics Management, Shanghai Jiao Tong University, Shanghai, China
    J Med Syst 36:979-94. 2012
    ....